Conferences
Breast Cancers
GI Cancers
Gynecologic Cancer
Head & Neck
Hematology
Lymphoma
Leukemia
Lung Cancers
Melanoma
Prostate Cancer
Urology
CLL
Pathways
More...
Giants

Urology

Feature
Latest Stories
Sipuleucel-T (Provenge), an immunotherapy tailor-made for men with metastatic castration-resistant prostate cancer (mCRPC) using their own white blood cells, is just as potent if it is manufactured while a patient is taking enzalutamide (Xtandi), and the two drugs seem to boost immunity more effectively when administered together.
Publications
$auto_registration$